Vaxcyte
PCVX
PCVX
334 hedge funds and large institutions have $9.44B invested in Vaxcyte in 2026 Q1 according to their latest regulatory filings, with 70 funds opening new positions, 129 increasing their positions, 80 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 294 → 334 (+40)
0.2% more ownership
Funds ownership: 112.72% → 112.93% (+0.2%)
37% less call options, than puts
Call options by funds: $64.8M | Put options by funds: $103M
Holders
334
Holding in Top 10
22
Calls
$64.8M
Puts
$103M
Top Buyers
| 1 | +$173M | |
| 2 | +$144M | |
| 3 | +$68.2M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$64.6M |
| 5 |
Jennison Associates
New York
|
+$55.4M |
Top Sellers
| 1 | -$74.6M | |
| 2 | -$41.6M | |
| 3 | -$29.3M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$20.8M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$19.1M |
